Skip to main content

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Ben Davis who has been announced as the recipient of the 2025 Claude S Hudson Award, presented by the American Chemical Society (ACS).

Professor Ben DavisThe Hudson Award is presented biennially by the ACS Division of Carbohydrate Chemistry & Chemical Glycobiology (CARB), committed to advancing the field of carbohydrate chemistry and chemical glycobiology through support and collaboration. The Award recognises outstanding contributions to carbohydrate chemistry in education, research, or applications and is presented to an individual who has made outstanding contributions to carbohydrate chemistry. 

Professor Davis holds a joint appointment between the Department of Pharmacology at the University of Oxford and Rosalind Franklin Institute (RFI), where he is Director of Next Generation Chemistry. 

In December 2021, the Department announced a strategic partnership in Next Generation Chemistry with the RFI which has seen the bilateral movement of researchers between the Franklin and Oxford, widening access to the cutting-edge facilities at Harwell. 

One of the key aims for the Davis group is to perform ‘in-cell chemistry’ – editing proteins and other biomolecules within the cell for therapeutic or diagnostic purposes. This work is revolutionary in its approach, and is highly complementary to other Franklin themes, including mass spectrometry imaging, structural biology, and correlated imaging. 

At the announcement of the award, Professor Davis said, “I am delighted and honoured to receive this award from the ACS. This reflects the support of both the Department of Pharmacology and the RFI to enable me and my group to continue to break boundaries in the area of carbohydrate chemistry and explore new and innovative research areas.” 

Similar stories

New Akerman group paper reveals links between sleep, synaptic inhibition, and the plastic changes that underlie learning in the brain

Pharmacology researchers have discovered a key mechanism linking sleep and wake to synaptic plasticity in the brain, shedding light on how learning and memory may be affected by rest. Their study, published by Alfonsa et al. in the journal Current Biology, reveals that intracellular chloride levels shift during sleep and wakefulness, influencing synaptic plasticity processes in the brain’s cortex.